UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.9139-9143

2004

Volltextzugriff (PDF)

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Clinical cancer research, 2003-08, Vol.9 (9), p.3246-3253

2003

Volltextzugriff (PDF)

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

Clinical cancer research, 2005-11, Vol.11 (21), p.7800-7806

2005

Volltextzugriff (PDF)

Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients

Clinical cancer research, 2004-12, Vol.10 (24), p.8341-8350

2004

Volltextzugriff (PDF)

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Clinical cancer research, 2001-08, Vol.7 (8), p.2292-2300

2001

Volltextzugriff (PDF)

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Clinical cancer research, 2001-10, Vol.7 (10), p.3229-3238

2001

Volltextzugriff (PDF)

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Clinical cancer research, 2004-03, Vol.10 (6), p.1976-1983

2004

Volltextzugriff (PDF)

Ductal access for prevention and therapy of mammary tumors

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.638-645

2006

Volltextzugriff (PDF)

Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel

Clinical pharmacology and therapeutics, 2004-05, Vol.75 (5), p.448-454

2004

Volltextzugriff (PDF)

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins

Clinical pharmacology and therapeutics, 2003-10, Vol.74 (4), p.364-371

2003

Volltextzugriff (PDF)

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

Clinical cancer research, 2005-10, Vol.11 (20), p.7398-7404

2005

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Clinical cancer research, 2005-01, Vol.11 (2), p.664-671

2005

Volltextzugriff (PDF)

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2003-03, Vol.51 (3), p.231-239

2003

Volltextzugriff (PDF)

Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-08, Vol.793 (2), p.413-420

2003

Volltextzugriff (PDF)

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Clinical cancer research, 2003-09, Vol.9 (10), p.3589-3597

2003

Volltextzugriff (PDF)

Tumor targeting by conjugation of DHA to paclitaxel

Journal of controlled release, 2001-07, Vol.74 (1), p.233-236

2001

Volltextzugriff (PDF)

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Clinical cancer research, 2006-01, Vol.12 (2), p.536-542

2006

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2604-2613

1999

Volltextzugriff (PDF)

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

Clinical cancer research, 2003, Vol.9 (1), p.151-159

2003

Volltextzugriff (PDF)

Troxacitabine, A Novel Dioxolane Nucleoside Analog, Has Activity in Patients With Advanced Leukemia

Journal of clinical oncology, 2001-02, Vol.19 (3), p.762-771

2001

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Clinical cancer research, 2000-01, Vol.6 (1), p.42-49

2000

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2459-2467

2000

Volltextzugriff (PDF)

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Clinical cancer research, 2006-04, Vol.12 (7), p.2158-2165

2006

Volltextzugriff (PDF)

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3085-3096

1996

Volltextzugriff (PDF)

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Journal of clinical oncology, 1996-12, Vol.14 (12), p.3074-3084

1996

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaAntineoplastic Agents

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(43)
Life Sciences & Biomedicine
(43)
Medical Sciences
(43)
Pharmacology. Drug Treatments
(43)
Science & Technology
(43)
Humans
(42)
Oncology
(38)
Female
(37)
Middle Aged
(35)
Adult
(34)
Chemotherapy
(34)
Male
(34)
Aged
(33)
Neoplasms - Drug Therapy
(24)
Dose-Response Relationship, Drug
(15)
Neoplasms - Metabolism
(14)
Antineoplastic Agents - Pharmacokinetics
(13)
Drug Administration Schedule
(13)
Infusions, Intravenous
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Ductal access for prevention and therapy of mammary tumors

Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel

Clinical pharmacokinetics of unbound docetaxel: Role of polysorbate 80 and serum proteins

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography–tandem mass spectrometry

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Tumor targeting by conjugation of DHA to paclitaxel

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies

Disposition of Docosahexaenoic acid-paclitaxel, a novel taxane, in blood: In vitro and clinical pharmacokinetic studies

Troxacitabine, A Novel Dioxolane Nucleoside Analog, Has Activity in Patients With Advanced Leukemia

A Phase I and Pharmacokinetic Study of the Mitochondrial-specific Rhodacyanine Dye Analog MKT 077

Population Pharmacokinetic Model for Topotecan Derived From Phase I Clinical Trials

Population Pharmacokinetics of Troxacitabine, a Novel Dioxolane Nucleoside Analogue

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence

Aktive Filter

Suchergebnisse filtern